Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations.
Bastie JN, Aucagne R, Droin N, Solary E, Delva L. Bastie JN, et al. Cell Mol Life Sci. 2012 Sep;69(17):2853-61. doi: 10.1007/s00018-012-0956-y. Epub 2012 Mar 14. Cell Mol Life Sci. 2012. PMID: 22415325 Free PMC article. Review.
Due to the restricted understanding of the mechanism involved in leukemogenesis, CMML still appears as a diagnostic and therapeutic undertaking, and poor prognosis of leukemia. Contrary to chronic myelogenous leukemia, BCR-ABL1-positive, …
Due to the restricted understanding of the mechanism involved in leukemogenesis, CMML still appears as a diagnostic and therapeutic undertak …
Chronic Myelogenous Leukemia Presenting as a Secondary Malignancy After BCR-ABL1-negative B-lymphoblastic Leukemia/Lymphoma in a Pediatric Patient.
Popa G, Blag C, Olteanu H. Popa G, et al. Pediatr Dev Pathol. 2017 Jan-Feb;20(1):58-62. doi: 10.1177/1093526616671047. Pediatr Dev Pathol. 2017. PMID: 28276292
Chronic myelogenous leukemia, BCR-ABL1 positive (CML) is a rare myeloproliferative neoplasm in children and presents even less often as a secondary malignancy in the pediatric population. ...
Chronic myelogenous leukemia, BCR-ABL1 positive (CML) is a rare myeloproliferative neoplasm in chi …
The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors.
Theil KS, Cotta CV. Theil KS, et al. Cancer Genet. 2014 May;207(5):171-6. doi: 10.1016/j.cancergen.2014.05.006. Epub 2014 May 21. Cancer Genet. 2014. PMID: 25027637
In chronic myelogenous leukemia, BCR-ABL1 positive detection of cytogenetic abnormalities in addition to the t(9;22) is thought to portend a poor prognosis; however, not all abnormalities associated with the t(9;22) have the same impact. …
In chronic myelogenous leukemia, BCR-ABL1 positive detection of cytogenetic abnormalities in addit …